1.

Catalogus van de boekerij der Nederlandsche keel-neus-oorheelkundige vereeniging.

1.

Catalogus van de boekerij der Nederlandsche keel- neus- oorheelkundige vereeniging. Supplement.

1.

ENT problems in Dutch Children: Trends in incidence rates, antibiotic prescribing and referrals 2002-2008

1.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency

2.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency

3.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency

4.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency

5.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency

6.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency

7.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency

8.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency

9.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency

1.

Elevation of D8/17-positive B lymphocytes in only a minority of Dutch patients with post-streptococcal reactive arthritis (PSRA): A pilot study [8]

2.

Elevation of D8/17-positive B lymphocytes in only a minority of Dutch patients with post-streptococcal reactive arthritis (PSRA): A pilot study [8]

3.

Elevation of D8/17-positive B lymphocytes in only a minority of Dutch patients with post-streptococcal reactive arthritis (PSRA): A pilot study [8]

1.

The number of symptoms reported by people requesting a SARS-CoV-2 test overall and by SARS-CoV-2 test result, from June 2020 through August 2021, Amsterdam region, the Netherlands.

1.

Results of the principal components analysis of COVID-19 symptoms.

1.

Flowchart of exclusions and records included in the analysis, Amsterdam region, the Netherlands, June 2020-August 2021.

1.

The prevalence of each symptom per month, from June 2020 through August 2021, the Amsterdam region, the Netherlands.

1.

Odds ratios and 95% confidence intervals per variable in the full multivariable logistic regression model per month, from June 2020 through August 2021, the Amsterdam region, the N...